Company Exagyn Srl with Fiscal Code 15494204
recorded a turnover of 2024 of
142.893,
with a net profit of
23.462
and having an average number of employees of
3.
The company operates in the field of Activităţi de asistenţă medicală specializată having the NACE code 8622.
Sales - Ron
Sales, Profit, Employees, Total Income, Financial Results -
Exagyn Srl
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Sales - EUR
85.495
92.773
92.748
106.339
123.064
75.269
78.034
93.254
121.066
142.893
Total Income - EUR
85.502
92.781
92.785
106.346
123.065
75.269
78.034
98.165
121.066
143.168
Total Expenses - EUR
80.932
83.583
65.947
73.169
77.791
47.088
47.334
65.957
90.480
115.505
Gross Profit/Loss - EUR
4.570
9.198
26.838
33.177
45.274
28.182
30.700
32.208
30.586
27.664
Net Profit/Loss - EUR
3.708
8.270
26.126
32.326
44.251
27.496
29.935
31.388
29.400
23.462
Employees
6
6
3
4
3
2
2
2
3
3
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded.
In the last year of activity, the sales increased by 18.7%, from 121.066 euro in the year 2023, to 142.893 euro in 2024.
The Net Profit decreased by -5.773 euro, from 29.400 euro in 2023, to 23.462 in the last year.
Check the financial reports for the company - Exagyn Srl
Financial Rating - EXAGYN SRL
See the company's note based on the submitted financial data, relative to the industry of which it is a part.
Financial Rating
Payment Limits - Exagyn Srl
See the company's payment capacity for situations in which you conclude contracts with payment terms.
Check Payment Limits
Prob. of insolvency - Exagyn Srl
It determines the risk of insolvency based on the submitted accounting balance.
Insolvency Probability
Financial Reports - Exagyn Srl
Check all the financial reports of the company and know the risks in collaboration with it.
Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of
19.980 euro in 2024 which includes Inventories of
588 euro, Receivables of
7.826 euro and cash availability of
11.566 euro.
The company's Equity was valued at
25.886 euro, while total Liabilities amounted to
30.996 euro.
Equity decreased by -6.693 euro, from 32.762 euro in 2023, to 25.886 in 2024.
Similar services useful for checking companies and business development.
SellNet
Get the contact details for any company and get in touch with it.
Sectoral Studies
Knows the market and develops its own development strategies according to sectorial data.
Databases
Export in excel files the data of the companies selected according to the desired criteria.
Import - Export
Find importers and exporters according to the type of activity and the countries in which they carry it out.
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.
Comments - Exagyn Srl